The Asia Pacific Point-of-care Ultrasound Market would witness market growth of 14.4% CAGR during the forecast period (2023-2030).In the year 2021, the Asia Pacific market's volume surged to 38,799.8 units, showcasing a growth of 15.2% (2019-2022).
Due to their various therapeutic and diagnostic applications, the demand for point-of-care ultrasounds is anticipated to increase in both developed and developing countries. Undifferentiated shock, cardiac arrest resuscitation, abdominal/thoracic trauma, pulmonary embolism, pericardial effusion, dyspnea, and abdominal pain are some conditions when POCUS is primarily used for diagnostic purposes.
For the treatment of pain, inflammation, and muscle spasm, POCUS is used. It is one of the main causes of the rising use of POCUS equipment in emergency rooms. The demand for in-house use is anticipated to increase due to a number of factors, including the growing popularity of these devices and the availability of increasingly affordable products.
As time passes, market growth is anticipated to be aided by the rise in patient visits to hospital emergency departments for an array of medical issues including acute abdominal pain, dyspnea, urology problems, pulmonary embolism, thoracic injuries, cardiac arrest resuscitation, pericardial effusion, muscle spasms, and chest pain. A significant driver propelling the POCUS market is the rising demand for diagnosis and treatment due to the growth in chronic diseases like acute coronary syndrome, aortic aneurysm, cholecystitis, etc. An ultrasound is used for disease detection and therapy, such as ultrasound-guided procedures.
According to data published by the Australian Government, there are expected to be 15,713 new cases of colorectal cancer detected in 2022 or 9.7% of the total cases. The probability of developing bowel cancer by age 85 is predicted to be 1 in 19 (or 5.2%) in 2022 (1 in 18 or 5.6% for men and 1 in 21 or 4.8% for women), according to the same source. A heightened awareness of colorectal cancer occurs due to the region's rising prevalence and rising disposable incomes. In order to assist with diagnosis, staging, treatment planning, and follow-up, point-of-care ultrasound, or POCUS, can play a crucial role in managing colorectal cancer. POCUS offers rapid and accessible imaging information. These factors make it feasible for the market to expand in this region.
The China market dominated the Asia Pacific Point-of-care Ultrasound Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $246.9 Million by 2030. The Japan market is registering a CAGR of 13.7% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 15.1% during (2023 - 2030).
Based on End User, the market is segmented into Hospitals, Clinics, and Others. Based on Product, the market is segmented into Cart-based, and Compact & Hand-held. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Point-of-care Ultrasound Market is Projected to reach USD 3.2 Billion by 2030, at a CAGR of 13.8%
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include GE HealthCare Technologies, Inc., Koninklijke Philips N.V., FUJIFILM Sonosite, Inc. (Fujifilm Holdings Corporation), Alpinion Medical Systems Co., Ltd. (ILJIN Group), Hitachi, Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Terason, Healcerion Co., Ltd., Edan Instruments, Inc. and Chilson Medical Technologies Co., Ltd.
By End User (Volume, Units, USD Million, 2019-2030)
By Product (Volume, Units, USD Million, 2019-2030)
By Country (Volume, Units, USD Million, 2019-2030)
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 